首页 | 本学科首页   官方微博 | 高级检索  
     

Vogt-小柳-原田综合征黄斑中心凹脉络膜厚度分析
引用本文:杜君,雷方. Vogt-小柳-原田综合征黄斑中心凹脉络膜厚度分析[J]. 眼科新进展, 2016, 0(8): 777-779. DOI: 10.13389/j.cnki.rao.2016.0208
作者姓名:杜君  雷方
作者单位:450052 河南省郑州市,郑州大学第一附属医院眼科(杜君);471003 河南省洛阳市,河南科技大学(雷方)
基金项目:郑州市技术研究与开发项目基金资助(121PCXTD523),Technology Research and Development Project of Zhengzhou(121PCXTD523)
摘    要:目的 分析Vogt-小柳-原田综合征患者急性期与恢复期黄斑中心凹下方脉络膜厚度(subfovealchoroidalthickness,SFCT)变化。方法 30例Vogt-小柳-原田综合征患者60眼纳入研究,其中男14例,女16例,年龄(45.38±10.19)岁。所有患者均行眼前节检查、最佳矫正视力、眼底彩色照相、眼底血管荧光造影(fundusfluoresceinangiography,FFA)及频域光学相干断层扫描(spectraldomainopticalcoherencetomography,SD-OCT)等检查确诊。经糖皮质激素口服治疗前及治疗2周、6个月、12个月后应用SD-OCT对Vogt-小柳-原田综合征患者进行深度加强扫描(enhanceddepthimaging,EDI)测量SFCT。与正常同龄人群SFCT值进行比较。结果 患眼与正常同龄人群SFCT值(287.85±27.70)μm比较,糖皮质激素治疗前,患眼SFCT厚度(437.46±30.14)μm明显增加,差异有统计学意义(t=3.591,P<0.01)。治疗2周后,患眼SFCT厚度为(352.50±60.37)μm,较治疗前显著下降,差异有统计学意义(t=2.567,P<0.05)。治疗6个月及12个月后,患眼SFCT厚度分别为(299.32±20.12)μm、(297.61±21.89)μm,与正常人群SFCT值比较,差异均无统计学意义(t=1.362、1.272,均为P>0.05)。结论 Vogt-小柳-原田综合征患者急性期SFCT较正常同龄人群明显增厚,恢复期与同龄正常人群比较无明显差别。

关 键 词:Vogt-小柳-原田综合征  黄斑中心凹脉络膜厚度  光学相干断层扫描  糖皮质激素

Subfoveal choroidal thickness in eyes with Vogt-Koyanagi-Harada disease
DU Jun,LEI Fang. Subfoveal choroidal thickness in eyes with Vogt-Koyanagi-Harada disease[J]. Recent Advances in Ophthalmology, 2016, 0(8): 777-779. DOI: 10.13389/j.cnki.rao.2016.0208
Authors:DU Jun  LEI Fang
Affiliation:Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University ( DU Jun ) , Zhengzhou 450052 . Henan Province , China ; The Henan University of Science and Technology ( LEI Fang ) , Luoyang 471003 ,Henan Province , China
Abstract:Objective To research the subfoveal choroidal thickness ( SFCT) in the acute and successive stages of Vogt-Koyanagi-Harada disease. Methods Thirty patients ( 60 eyes) with VKH were enrolled in this study. The patients included 14 males and 16 females,with a mean age of (45. 38 + 10. 19) years old. A1l the patients that had been exanuned slit-lamp check,best corrected visual acuity ( BCVA) ,fundus color photography,fundus fluorescein angiography ( FFA) and spectral domain optical coherence tomography ( SD-OCT) were recuited. Glucocorticoid was administered to all patients. The SFCT were measured by SD-OCT with enhanced depth imaging ( EDI) on all the patients before the treatment and 2 weeks ,6 months and 12 months after treatment . and was compared with the average SFCT in normal eyes. Results Before treatment , SFCT of affected eyes was (437. 46 +30. 14) Vm,which was significantly thicker than normal SFCT ( 287. 85 + 27. 70) Vm( t = 3. 591 ,P < 0. 01 ) . Two weeks after treatment . SFCT of affected eyes was( 352. 50 +60. 37) ym , and was significantly thinner than that before treatment ( t = 2. 567 .P < 0. 05) . SFCT of affected eyes at 6 months and 12 months after treatment were (299. 32 + 20. 12) Vm ( 297. 61 + 21. 89) Vm, respectively , there was no significant difference compared with normal eyes ( t = 1. 362 . 1. 272 ; all P > 0. 05 ) . Conclusion SFCT in the acute stages of VKH patients is significantly thicker than that in normal subjects , and no difference in successive stages of VKH patients.
Keywords:Vogt-Koyanagi-Harada disease  subfoveal choroidal thickness  optical coherence tomography  glucocorticoid
本文献已被 万方数据 等数据库收录!
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号